These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23731130)

  • 1. Positive compared with negative margins in a single-centre retrospective study on 3957 consecutive excisions of basal cell carcinomas. Associated risk factors and preferred surgical management.
    Codazzi D; Van Der Velden J; Carminati M; Bruschi S; Bocchiotti MA; Di Serio C; Barberis M; Robotti E
    J Plast Surg Hand Surg; 2014 Feb; 48(1):38-43. PubMed ID: 23731130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases.
    Farhi D; Dupin N; Palangié A; Carlotti A; Avril MF
    Dermatol Surg; 2007 Oct; 33(10):1207-14. PubMed ID: 17903153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete primary excision of cutaneous basal and squamous cell carcinomas in the Bay of Plenty.
    Talbot S; Hitchcock B
    N Z Med J; 2004 Apr; 117(1192):U848. PubMed ID: 15107870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basal cell carcinomata: Risk factors for incomplete excision and results of re-excision.
    Masud D; Moustaki M; Staruch R; Dheansa B
    J Plast Reconstr Aesthet Surg; 2016 May; 69(5):652-6. PubMed ID: 26948998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of periocular basal and squamous cell carcinoma: a series of 485 cases.
    Nemet AY; Deckel Y; Martin PA; Kourt G; Chilov M; Sharma V; Benger R
    Am J Ophthalmol; 2006 Aug; 142(2):293-7. PubMed ID: 16876511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective study of 694 Basal Cell Carcinoma excisions to quantify deep margin documentation and clearance compared to histological type and surgical margin.
    Kiely JR; Patel AJK
    J Plast Reconstr Aesthet Surg; 2019 Nov; 72(11):1805-1812. PubMed ID: 31331722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
    Palmer VM; Wilson PR
    Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological variation of incompletely excised basal cell carcinoma's and the variation with the grade of surgeon - implications for revalidation.
    Robinson AJ; Walsh M; Hill C
    Eur J Surg Oncol; 2015 Jan; 41(1):165-8. PubMed ID: 25468457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Audit of histologically incompletely excised basal cell carcinomas: recommendations for management by re-excision.
    Griffiths RW
    Br J Plast Surg; 1999 Jan; 52(1):24-8. PubMed ID: 10343586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors contributing to incomplete excision of nonmelanoma skin cancer by Australian general practitioners.
    Hansen C; Wilkinson D; Hansen M; Soyer HP
    Arch Dermatol; 2009 Nov; 145(11):1253-60. PubMed ID: 19917954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
    Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
    Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basal cell carcinomas: do they need to be followed up?
    Park AJ; Strick M; Watson JD
    J R Coll Surg Edinb; 1994 Apr; 39(2):109-11. PubMed ID: 7520063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions.
    Bartoš V; Pokorný D; Zacharová O; Haluska P; Doboszová J; Kullová M; Adamicová K; Péč M; Péč J
    Acta Dermatovenerol Alp Pannonica Adriat; 2011 Jun; 20(2):67-75. PubMed ID: 21993704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.
    Boulinguez S; Grison-Tabone C; Lamant L; Valmary S; Viraben R; Bonnetblanc JM; Bédane C
    Br J Dermatol; 2004 Sep; 151(3):623-6. PubMed ID: 15377349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An assessment of incomplete facial Basal cell carcinoma excision.
    Shah SA; Obaidullah ; Fahimullah
    J Coll Physicians Surg Pak; 2005 Mar; 15(3):149-51. PubMed ID: 15808092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole specimen intraoperative frozen section analysis. Experience with 1082 basal cell carcinomas.
    Kedilioglu MA; Bos PG; De Jong K; Noordzij NA; Kibbelaar RE; Lapid O; Mouës CM
    Eur J Surg Oncol; 2018 Jan; 44(1):157-162. PubMed ID: 29198817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for recurrence of facial basal cell carcinoma after surgical excision: A follow-up analysis.
    Armstrong LTD; Magnusson MR; Guppy MPB
    J Plast Reconstr Aesthet Surg; 2017 Dec; 70(12):1738-1745. PubMed ID: 28579037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
    Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
    J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A five year review of basal cell carcinoma excisions.
    Sherry KR; Reid LA; Wilmshurst AD
    J Plast Reconstr Aesthet Surg; 2010 Sep; 63(9):1485-9. PubMed ID: 19837017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
    Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
    Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.